References
- Verspohl EJ. Novel pharmacological approaches to the treatment of schizophrenia. Dan Med Bull 2000;47:151–67.
- Hegazi R, El-gamal M, Abdel-hady N. Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Glob Heal 2015;81:814–20. [Internet]. Available from: http://dx.doi.org/10.1016/j.aogh.2015.12.011
- Bhaskar Kumar T, Sumanth C, Vaishaly S, et al. Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4. Bioorg Med Chem Lett 2012;22:5639–47. [Internet]. [cited 2015 Feb 14]Available from: http://www.ncbi.nlm.nih.gov/pubmed/22871579
- Zeng S, Xie H, Zeng LL, et al. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization. Bioorganic Med Chem 2013;21:1749–55. [Internet]. Available from: http://dx.doi.org/10.1016/j.bmc.2013.01.062
- Deng J, Peng L, Zhang G, et al. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. Eur J Med Chem 2011;46:71–6. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21106276
- Jones RB, Dickinson K, Anthony DM, et al. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. Br J Pharmacol 1997;120:1135–43.
- Goel A, Agarwal N, Singh FV, et al. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models. Bioorg Med Chem Lett 2004;14:1089–92.
- Bhardwaj V, Gumber D, Abbot V, et al. Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics. RSC Adv 2015;5:15233–66. [Internet]. Available from: http://xlink.rsc.org/?DOI=C4RA15710A
- Kondo T, Nekado T, Sugimoto I, et al. Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group. Bioorg Med Chem 2008;16:1613–31. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18039579
- Simpkins LM, Bolton S, Pi Z, et al. Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 2007;17:6476–80. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17937986
- Han B, Liu JL, Huan Y, et al. Design, synthesis and primary activity of thiomorpholine derivatives as DPP-IV inhibitors. Chinese Chem Lett 2012;23:297–300. [Internet]. [cited 2015 Feb 14]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1001841711003640
- Nishio Y, Kimura H, Uchiyama K, et al. One-pot synthesis of 5-amino 4-cyano pyrrole derivatives. Tetrahedron Lett 2011;52:2767–70. [Internet]. [cited 2015 Feb 14]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0040403911004692
- Motoshima K, Sugita K, Hashimoto Y, Ishikawa M. Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonists. Bioorg Med Chem Lett 2011;21:3041–5. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21478015
- Andrews KM, Beebe D. a, Benbow JW, et al. 1-((3S,4S)-4-Amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes. Bioorganic Med Chem Lett 2011;21:1810–4. [Internet]. Available from: http://dx.doi.org/10.1016/j.bmcl.2011.01.055
- Zhao G, Kwon C, Wang A, et al. Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors. Bioorganic Med Chem Lett 2013;23:1622–5. [Internet]. Available from: http://dx.doi.org/10.1016/j.bmcl.2013.01.104
- Tsai T-Y, Hsu T, Chen C-T, et al. Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 2009;19:1908–12. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19269819
- Gao Y-D, Feng D, Sheridan RP, et al. Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors. Bioorg Med Chem Lett 2007;17:3877–9. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17502141
- Xie H, Zeng L, Zeng S, et al. Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization. Eur J Med Chem 2012;52:205–12. [Internet]. Available from: http://dx.doi.org/10.1016/j.ejmech.2012.03.015
- Zhu X, Huang W, Qian H. GPR119 agonists: a novel strategy for type 2 diabetes treatment. Open Sci 2013;119:61–82.
- Abu-Hashem AA. Synthesis and reaction of novel spiro pyrimidine derivatives. J Heterocycl Chem 2014;51:1020–6.
- Bälter M, Hammarson M, Remón P, et al. Reversible energy-transfer switching on a DNA scaffold. J Am Chem Soc. 2015;137(7):2444–2447. [Internet]. Available from: http://pubs.acs.org/doi/abs/10.1021/ja512416n
- Li Z, Zhu A, Yang J. One-pot three-component mild synthesis of 2-aryl-3-(9-alkylcarbazol-3-yl)thiazolin-4-ones. J Heterocycl Chem 2012;49:1458–61.
- Abdel-Hafez SH. Selenium containing heterocycles: synthesis, anti-inflammatory, analgesic and anti-microbial activities of some new 4-cyanopyridazine-3(2H)selenone derivatives. Eur J Med Chem 2008;43:1971–7.
- Khloya P, Kumar P, Mittal A, et al. Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents. Org Med Chem Lett 2013;3:9. [Internet]. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=37659-36&tool=pmcentrez&rendertype=abstract
- Karpyak VV, Obushak MD, Ganushchak MI. Synthesis of 2-(2-R1-hydrazino)-5-(R2-benzyl)-2-thiazolines on the basis of Meerweins Arylation products of allyl isothiocyanate. Molecules 2003;8:263–8.
- Flefel EM, El-Sayed WA, Mohamed AM, et al. Synthesis and anticancer activity of new 1-thia-4-azaspiro[4.5]decane, their derived thiazolopyrimidine and 1,3,4-thiadiazole thioglycosides. Molecules 2017;22:1–13.
- Mohamed MS, Ali S, Abdelaziz DHA, Fathallah SS. Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents. Biomed Res Int 2014;2014:1–13.
- Mohamed MS, El-Domany RA, Abd El-Hameed RH, et al. Synthesis of certain pyrrole derivatives as antimicrobial agents. Acta Pharm 2009;59:145–58.
- Hussein WM, Fatahala SS, Mohamed ZM, et al. Synthesis and kinetic testing of tetrahydropyrimidine-2-thione and pyrrole derivatives as inhibitors of the metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Chem Biol Drug Des 2012;80:500–15. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22738437
- Mohamed MS, Kamel R, Abd El-hameed RH. Evaluation of the anti-inflammatory activity of some pyrrolo[2,3-d]pyrimidine derivatives. Med Chem Res 2012;22:2244–52. [Internet]. [cited 2015 Feb 14]. Available from: http://link.springer.com/10.1007/s00044-012-0217-5
- Mohamed MS, Kamel R, Fatahala SS. New condensed pyrroles of potential biological interest: syntheses and structure-activity relationship studies. Eur J Med Chem. 2011;46:3022–9. [Internet]. Available from: http://dx.doi.org/10.1016/j.ejmech.2011.04.034
- Mohamed MS, Kamel R, Fatahala SS. Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities. Eur J Med Chem 2010;45:2994–3004. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20399543
- Mohamed MS, Ali SA, Abdelaziz DHA, Fathallah SS. Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as antihypoglycemic agents. Biomed Res Int2014;2014:249780. [Internet]. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099110&tool=pmcentrez&ren-dertype=abstract
- Mohamed MS, Kamel R, Fathallah SS. Synthesis of new pyrroles of potential anti-inflammatory activity. Arch Pharm (Weinheim) 2011;344:830–9. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21956581
- Mowla A, Alauddin M, Rahman MA, Ahmed K. Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract. African J Tradit Complement Altern Med 2009;6:255–61.
- Singh FV, Parihar A, Chaurasia S, et al. 5,6-Diarylanthranilo-1,3-dinitriles as a new class of antihyperglycemic agents. Bioorg Med Chem Lett 2009;19:2158–61. [Internet]. [cited 2015 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19303291
- Nagasawa T, Tabata N, Ito Y, et al. Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats. Mol Cell Biochem 2003;252:141–7.
- Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol 2012;142:65–71.
- Kim NN, Stankovic M, Cushman TT, et al. Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers. BMC Physiol 2006;6:4.
- Fatahala S, Shalaby E, Kassab S, Mohamed M. A promising anti-cancer and anti-oxidant agents based on the pyrrole and fused pyrrole: synthesis, docking studies and biological evaluation. Anticancer Agents Med Chem. 2015;15:517–26. [Internet]. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5206&volume=15&issue =4&spage =517
- Fatahala SS, Hasabelnaby S, Goudah A, et al. Pyrrole and fused pyrrole compounds with bioactivity against inflammatory mediators. Molecules 2017;22(426):1–18.
- Fatahala SS, Mohamed MS, Youns M, Hameed RHA-E. Synthesis and evaluation of cytotoxic activity of some pyrroles and fused pyrroles. Anticancer Agents Med Chem 2017;17:1–12.
- Abdel-rahman AE, Awad IM, Bakhite E. Synthesis of some new heterocyclic compounds containing thieno[2,3-b]quinoline moiety. Phosphorus Sulfur Silicon Relat Elem 1991;60:189–99. [Internet]. [cited 2015 Feb 14]. Available from: http://www.tandfonline.com/doi/abs/10.1080/1042650-9108036781
- Ismail MM, Abass M, Hassan MM. Chemistry of substituted quinolinones: part VI. Synthesis and nucleophilic reactions of 4-chloro-8-methylquinolin-2(1H)-one and its thione analogue. Molecules 2000;5:1224–39.
- Sayed Mohamed M, Goudah Mostafa A, Helmy Abd El-hameed R. Evaluation of the anti-inflammatory activity of novel synthesized pyrrole, pyrrolopyrimidine and spiropyrrolopyrimidine derivatives. Pharmacophore 2012;3:44–54. [Internet]. Available from: http://www.pharmacophorejournal.com
- Uma C, Suganya N, Vanitha P, et al. Antihyperglycemic effect of Codariocalyx motorius modulated carbohydrate metabolic enzyme activities in streptozotocin-induced diabetic rats. J Funct Foods 2014;11:517–27. [Internet]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1756464614002564
- Sheikh BA, Pari L, Rathinam A, Chandramohan R. Trans-anethole, a terpenoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats. Biochimie 2015;112:57–65. [Internet]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0300908415000437
- Review P. In vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina. Asian Pac J Trop Biomed 2014;4(Suppl 1). [Internet]. Available from. http://www.apjtb.com/zz/2014S1/81.pdf
- Sivajothi V, Dakappa SS. In vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina. Asian Pac J Trop Biomed 2014;4(Suppl 1):S454–S459.